tirzepatide children What Is Used for? Approved and Potential Uses Weight-Loss Drugs for Kids: Patients
Description
In the SURMOUNT-1 trial, the 5mg group averaged 16% total body weight loss over 72 weeks
Stay upright for 90 minutes post-injection
Administered as a weekly subcutaneous injection, users typically select a routine day for ease
This weight reduction is particularly beneficial for non-diabetic individuals as well, helping to lower the risk of developing obesity-related conditions
The percentage of participants receiving tirzepatide or placebo who reported nausea, vomiting, or diarrhea are presented
